Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA.
J Immunol. 2010 Dec 1;185(11):7097-106. doi: 10.4049/jimmunol.1002751. Epub 2010 Nov 1.
Breast milk transmission of HIV remains an important mode of infant HIV acquisition. Enhancement of mucosal HIV-specific immune responses in milk of HIV-infected mothers through vaccination may reduce milk virus load or protect against virus transmission in the infant gastrointestinal tract. However, the ability of HIV/SIV strategies to induce virus-specific immune responses in milk has not been studied. In this study, five uninfected, hormone-induced lactating, Mamu A*01(+) female rhesus monkey were systemically primed and boosted with rDNA and the attenuated poxvirus vector, NYVAC, containing the SIVmac239 gag-pol and envelope genes. The monkeys were boosted a second time with a recombinant Adenovirus serotype 5 vector containing matching immunogens. The vaccine-elicited immunodominant epitope-specific CD8(+) T lymphocyte response in milk was of similar or greater magnitude than that in blood and the vaginal tract but higher than that in the colon. Furthermore, the vaccine-elicited SIV Gag-specific CD4(+) and CD8(+) T lymphocyte polyfunctional cytokine responses were more robust in milk than in blood after each virus vector boost. Finally, SIV envelope-specific IgG responses were detected in milk of all monkeys after vaccination, whereas an SIV envelope-specific IgA response was only detected in one vaccinated monkey. Importantly, only limited and transient increases in the proportion of activated or CCR5-expressing CD4(+) T lymphocytes in milk occurred after vaccination. Therefore, systemic DNA prime and virus vector boost of lactating rhesus monkeys elicits potent virus-specific cellular and humoral immune responses in milk and may warrant further investigation as a strategy to impede breast milk transmission of HIV.
母乳传播仍然是婴儿 HIV 感染的重要途径。通过疫苗接种增强 HIV 感染母亲乳汁中黏膜 HIV 特异性免疫应答,可能会降低乳汁中的病毒载量或防止病毒在婴儿胃肠道中传播。然而,尚未研究 HIV/SIV 策略诱导乳汁中病毒特异性免疫应答的能力。在这项研究中,五头未感染的、激素诱导泌乳的、Mamu A*01(+)雌性恒河猴接受了 rDNA 和减毒痘苗载体 NYVAC 的系统初次免疫和加强免疫,该载体含有 SIVmac239 gag-pol 和包膜基因。这些猴子用含有匹配免疫原的重组腺病毒血清型 5 载体进行了第二次加强免疫。疫苗诱导的乳汁中免疫显性表位特异性 CD8(+)T 淋巴细胞应答的幅度与血液和阴道相似或更大,但高于结肠。此外,在每次病毒载体加强免疫后,疫苗诱导的 SIV Gag 特异性 CD4(+)和 CD8(+)T 淋巴细胞多功能细胞因子应答在乳汁中的反应比在血液中更强烈。最后,所有接种疫苗的猴子的乳汁中都检测到了 SIV 包膜特异性 IgG 应答,而只有一只接种疫苗的猴子的乳汁中检测到了 SIV 包膜特异性 IgA 应答。重要的是,接种疫苗后,乳汁中活化或 CCR5 表达的 CD4(+)T 淋巴细胞的比例仅出现有限且短暂的增加。因此,对哺乳期恒河猴进行系统 DNA 初免和病毒载体加强免疫可在乳汁中引发强烈的病毒特异性细胞和体液免疫应答,可能值得进一步研究作为阻止 HIV 通过母乳传播的策略。